POVIDONE IODINE

Povidone Iodine Adverse Events Reported to the FDA Over Time

How are Povidone Iodine adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Povidone Iodine, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Povidone Iodine is flagged as the suspect drug causing the adverse event.

Most Common Povidone Iodine Adverse Events Reported to the FDA

What are the most common Povidone Iodine adverse events reported to the FDA?

Toxic Anterior Segment Syndrome	36 (4.55%)
Conjunctival Oedema	31 (3.92%)
Exophthalmos	27 (3.41%)
Parophthalmia	27 (3.41%)
Endophthalmitis	26 (3.29%)
Visual Acuity Reduced	24 (3.03%)
Drug Hypersensitivity	23 (2.91%)
Intraocular Pressure Increased	18 (2.28%)
Post Procedural Complication	18 (2.28%)
Renal Failure Acute	18 (2.28%)
Oliguria	16 (2.02%)
	Show More
Eye Pain	15 (1.9%)
Haematuria	12 (1.52%)
Chemical Burn Of Skin	9 (1.14%)
Erythema	9 (1.14%)
Lymphopenia	9 (1.14%)
Pyrexia	8 (1.01%)
Skin Test Positive	8 (1.01%)
Back Pain	7 (.88%)
Eyelid Oedema	7 (.88%)
Iridocyclitis	7 (.88%)
Ocular Hypertension	7 (.88%)
Cardiac Arrest	6 (.76%)
Papilloedema	6 (.76%)
Rash	6 (.76%)
Bacterial Infection	5 (.63%)
Detachment Of Retinal Pigment Epith...	5 (.63%)
Eye Inflammation	5 (.63%)
Haemolysis	5 (.63%)
Hypotension	5 (.63%)
Hypothyroidism	5 (.63%)
Retinal Haemorrhage	5 (.63%)
Abscess	4 (.51%)
Anaphylactic Reaction	4 (.51%)
Body Temperature Decreased	4 (.51%)
Bradycardia	4 (.51%)
Condition Aggravated	4 (.51%)
Dermatitis Contact	4 (.51%)
Dysphagia	4 (.51%)
Dyspnoea	4 (.51%)
Eye Movement Disorder	4 (.51%)
Haemorrhage	4 (.51%)
Hypersensitivity	4 (.51%)
Inflammation	4 (.51%)
Mass	4 (.51%)
Muscle Swelling	4 (.51%)
Pain	4 (.51%)
Staphylococcal Abscess	4 (.51%)
Ventricular Fibrillation	4 (.51%)
Anaphylactic Shock	3 (.38%)
Application Site Erythema	3 (.38%)
Blood Pressure Decreased	3 (.38%)
Burning Sensation	3 (.38%)
C-reactive Protein Increased	3 (.38%)
Cataract Operation Complication	3 (.38%)
Cough	3 (.38%)
Disease Recurrence	3 (.38%)
Disorder Of Orbit	3 (.38%)
Drug Effect Decreased	3 (.38%)
Drug Ineffective	3 (.38%)
Fistula	3 (.38%)
Headache	3 (.38%)
Macular Oedema	3 (.38%)
Malaise	3 (.38%)
Oedema	3 (.38%)
Overdose	3 (.38%)
Platelet Count Decreased	3 (.38%)
Post Procedural Haematuria	3 (.38%)
Productive Cough	3 (.38%)
Pruritus	3 (.38%)
Purulent Discharge	3 (.38%)
Urticaria	3 (.38%)
White Blood Cell Count Increased	3 (.38%)
Acute Generalised Exanthematous Pus...	2 (.25%)
Anaphylactoid Reaction	2 (.25%)
Asthma	2 (.25%)
Blood Pressure Increased	2 (.25%)
Body Temperature Increased	2 (.25%)
Bone Density Decreased	2 (.25%)
Bronchospasm	2 (.25%)
Burns Second Degree	2 (.25%)
Cataract	2 (.25%)
Caustic Injury	2 (.25%)
Chest Discomfort	2 (.25%)
Chest Pain	2 (.25%)
Conjunctivitis	2 (.25%)
Corneal Erosion	2 (.25%)
Death	2 (.25%)
Decreased Appetite	2 (.25%)
Diarrhoea	2 (.25%)
Discomfort	2 (.25%)
Disease Progression	2 (.25%)
Drug Eruption	2 (.25%)
Drug Exposure During Pregnancy	2 (.25%)
Endocarditis	2 (.25%)
Eye Operation Complication	2 (.25%)
Eye Swelling	2 (.25%)
Gangrene	2 (.25%)
Hypertension	2 (.25%)
Increased Viscosity Of Bronchial Se...	2 (.25%)
Intraocular Pressure Test	2 (.25%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Povidone Iodine, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Povidone Iodine is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Povidone Iodine

What are the most common Povidone Iodine adverse events reported to the FDA?

Ocular Infections, Irritations And ...	85 (10.75%)
Procedural And Device Related Injur...	69 (8.72%)
Epidermal And Dermal Conditions	44 (5.56%)
Infections - Pathogen Unspecified	42 (5.31%)
Ocular Structural Change, Deposit A...	41 (5.18%)
Renal Disorders	40 (5.06%)
Allergic Conditions	39 (4.93%)
Vision	26 (3.29%)
Eye	23 (2.91%)
Respiratory	23 (2.91%)
Neurological, Special Senses And Ps...	22 (2.78%)
	Show More
Cardiac Arrhythmias	16 (2.02%)
Chemical Injury And Poisoning	16 (2.02%)
Bacterial Infectious	13 (1.64%)
Urinary Tract Signs	12 (1.52%)
Administration Site Reactions	11 (1.39%)
Immunology And Allergy	10 (1.26%)
Musculoskeletal And Connective Tiss...	10 (1.26%)
Cardiac And Vascular Investigations	9 (1.14%)
White Blood Cell	9 (1.14%)
Body Temperature Conditions	8 (1.01%)
Decreased And Nonspecific Blood Pre...	8 (1.01%)
Anterior Eye Structural Change, Dep...	7 (.88%)
Glaucoma And Ocular Hypertension	7 (.88%)
Hematology Investigations	7 (.88%)
Neurological	7 (.88%)
Gastrointestinal Signs	6 (.76%)
Injuries	6 (.76%)
Medication Errors	6 (.76%)
Physical Examination Topics	6 (.76%)
Retina, Choroid And Vitreous Hemorr...	6 (.76%)
Therapeutic And Nontherapeutic Effe...	6 (.76%)
Thyroid Gland	6 (.76%)
Angiedema And Urticaria	5 (.63%)
Hemolyses And Related Conditions	5 (.63%)
Ocular Neuromuscular	5 (.63%)
Oral Soft Tissue Conditions	5 (.63%)
Bronchial Disorders	4 (.51%)
Fungal Infectious	4 (.51%)
Headaches	4 (.51%)
Muscle	4 (.51%)
Tissue	4 (.51%)
Vascular Hemorrhagic	4 (.51%)
Eye Therapeutic Procedures	3 (.38%)
Gastrointestinal Motility And Defec...	3 (.38%)
Injuries By Physical Agents	3 (.38%)
Product Quality Issues	3 (.38%)
Protein And Chemistry Analyses	3 (.38%)
Viral Infectious	3 (.38%)
Acid-base	2 (.25%)
Appetite And General Nutritional	2 (.25%)
Cardiac Disorder Signs	2 (.25%)
Fatal Outcomes	2 (.25%)
Joint	2 (.25%)
Maternal Complications Of Pregnancy	2 (.25%)
Microbiology And Serology	2 (.25%)
Musculoskeletal And Soft Tissue Inv...	2 (.25%)
Platelet	2 (.25%)
Skin Vascular Abnormalities	2 (.25%)
Vascular Hypertensive	2 (.25%)
Abortions And Stillbirth	1 (.13%)
Bone And Joint Injuries	1 (.13%)
Central Nervous System Vascular	1 (.13%)
Fetal Complications	1 (.13%)
Head And Neck Therapeutic Procedure...	1 (.13%)
Hematological	1 (.13%)
Immune	1 (.13%)
Immunodeficiency Syndromes	1 (.13%)
Investigations, Imaging And Histopa...	1 (.13%)
Lipid Analyses	1 (.13%)
Lower Respiratory Tract Disorders	1 (.13%)
Maternal Complications Of Labour An...	1 (.13%)
Metabolic, Nutritional And Blood Ga...	1 (.13%)
Mood Disorders	1 (.13%)
Peritoneal And Retroperitoneal Cond...	1 (.13%)
Pleural	1 (.13%)
Renal And Urinary Tract Investigati...	1 (.13%)
Respiratory And Pulmonary Investiga...	1 (.13%)
Schizophrenia And Other Psychotic	1 (.13%)
Seizures	1 (.13%)
Skin And Subcutaneous Tissue Disord...	1 (.13%)
Skin Appendage Conditions	1 (.13%)
Spinal Cord And Nerve Root	1 (.13%)
Spleen, Lymphatic And Reticulendoth...	1 (.13%)
Toxicology And Therapeutic Drug Mon...	1 (.13%)
Upper Respiratory Tract Disorders	1 (.13%)
Water, Electrolyte And Mineral	1 (.13%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Povidone Iodine, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Povidone Iodine is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.